Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Overcoming structural barriers to tuberculosis treatment in Africa through digital technologies.
Journal: The Lancet. Microbe
Published: February 10, 2026
Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: June 16, 2025
The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution.
Journal: American journal of respiratory and critical care medicine
Published: June 12, 2025
Blasto-ing through the chest wall: Empyema necessitans due to pulmonary blastomycosis.
Journal: IDCases
Published: September 22, 2024
Contemporary management of multi-drug resistant tuberculosis.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: December 12, 2023
HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic.
Journal: Drugs
Published: October 18, 2023
Pulmonary tuberculosis complicated by pneumothorax, and acute respiratory distress syndrome (ARDS) in the settings of advanced HIV disease: A case report.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: September 22, 2023
Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 14, 2023
Pharmacogenomic panel testing provides insight and enhances medication management in people with HIV.
Journal: AIDS (London, England)
Published: May 18, 2023
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Journal: Lancet (London, England)
Published: March 23, 2023
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 13, 2023
Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection.
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: January 18, 2023
Last Updated: 09/26/2026